Who owns Alnylam Pharmaceuticals?

Key details on Alnylam Pharmaceuticals (Ticker: ALNY)

Who owns Alnylam Pharmaceuticals?

Is ALNY a good stock to own? Find out who bought Alnylam Pharmaceuticals, who sold Alnylam Pharmaceuticals (ALNY) stock, and who holds a large position in Alnylam Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 11.45M $894.50M Sept. 30, 2014
Wellington Management Company 8.95M $867.87M Dec. 31, 2014
Vanguard 3.72M $360.95M Dec. 31, 2014
Franklin Resources 2.14M $207.43M Dec. 31, 2014
Capital World Investors^ 2.02M $189.27M Dec. 31, 2014
Gilder, Gagnon, Howe & Co 2.00M $126.08M Dec. 31, 2014
Columbia Wanger Asset Management 1.91M $122.87M Dec. 31, 2013
HealthCor Management 1.80M $16.87M June 30, 2011
Schroder Investment Management 1.64M $105.18M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 1.60M $155.52M Dec. 31, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.60M $155.39M Dec. 31, 2014
BlackRock Fund Advisors 1.46M $141.17M Dec. 31, 2014
HealthCor Management 1.45M $35.34M March 31, 2013
MORGAN STANLEY 1.38M $133.51M Dec. 31, 2014
Falcon Edge Capital 1.37M $132.67M Dec. 31, 2014
Bridger Management 1.37M $33.31M March 31, 2013
T. Rowe Price Associates 1.24M $120.48M Dec. 31, 2014
Deerfield Management Company 1.22M $29.77M March 31, 2013
CITADEL ADVISORS 1.19M $36.84M June 30, 2013
Jennison Associates 1.13M $88.11M Sept. 30, 2014
Abingworth 1.11M $20.29M Dec. 31, 2012
BlackRock Advisors 1.10M $70.19M Sept. 30, 2013
BAILLIE GIFFORD & CO 1.09M $106.06M Dec. 31, 2014
STATE STREET CORPORATION 1.07M $103.85M Dec. 31, 2014
LORD, ABBETT & CO 1.03M $31.83M June 30, 2013
Wells Fargo & Company 1.01M $63.79M June 30, 2014
Columbus Circle Investors 1.00M $67.43M March 31, 2014
Camber Capital Management 1000000 $31.01M June 30, 2013